Production (Stage)
Altamira Therapeutics Ltd.
CYTOF
$0.10
$0.00060.60%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.00% | 1,424.58% | 0.00% | -91.07% | 0.00% |
| Total Receivables | 0.00% | 189.61% | 0.00% | 36.45% | 0.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 0.00% | -97.87% | 0.00% | -11.22% | 0.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | -27.86% | 0.00% | -52.03% | 0.00% |
| Total Current Assets | 0.00% | 193.99% | 0.00% | -63.95% | 0.00% |
|
|
|||||
| Total Current Assets | 0.00% | 193.99% | 0.00% | -63.95% | 0.00% |
| Net Property, Plant & Equipment | 0.00% | 7.73% | 0.00% | 338.66% | 0.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 0.00% | 7.22% | 0.00% | -11.75% | 0.00% |
|
|
|||||
| Total Accounts Payable | 0.00% | -0.34% | 0.00% | 7.27% | 0.00% |
| Total Accrued Expenses | 0.00% | -15.23% | 0.00% | 39.42% | 0.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.00% | -0.81% | 0.00% | 4.22% | 0.00% |
| Total Finance Division Other Current Liabilities | 0.00% | -- | -- | -- | 0.00% |
| Total Other Current Liabilities | 0.00% | -- | -- | -- | 0.00% |
| Total Current Liabilities | 0.00% | -5.18% | 0.00% | 16.25% | 0.00% |
|
|
|||||
| Total Current Liabilities | 0.00% | -5.18% | 0.00% | 16.25% | 0.00% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 0.00% | -21.51% | 0.00% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 212.52% | 0.00% | -46.86% | 0.00% |
| Total Liabilities | 0.00% | 19.20% | 0.00% | 19.25% | 0.00% |
|
|
|||||
| Common Stock & APIC | 0.00% | 75.47% | 0.00% | -99.98% | 0.00% |
| Retained Earnings | 0.00% | -340.87% | 0.00% | 105.89% | 0.00% |
| Treasury Stock & Other | 0.00% | 89.65% | 0.00% | -1.46% | 0.00% |
| Total Common Equity | 0.00% | 3.91% | 0.00% | -17.68% | 0.00% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 0.00% | 3.91% | 0.00% | -17.68% | 0.00% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 0.00% | 3.91% | 0.00% | -17.68% | 0.00% |
|
|
|||||